High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma |
| |
Authors: | I. E. Smith B. D. Evans S. J. Harland B. A. Robinson J. R. Yarnold J. G. Glees H. T. Ford |
| |
Affiliation: | (1) The Lung Unit, Royal Marsden Hospital, Sutton, Surrey, England |
| |
Abstract: | Summary Whithin an original consecutive series of 94 patients, 36 eligible patients with small cell lung carcinoma were treated with high-dose cyclophosphamide 7 g/m2 after conventional chemotherapy with VP16, adriamycin, and vincristine. The first 17 also underwent autologous bone marrow rescue. Treatment was well tolerated apart from one treatment-related death. Measurable tumour was still present in 15 patients before high-dose cyclophosphamide, and although 12 (80%) of these achieved further tumour response, these responses were all short-lived, with a median duration of 9 weeks. In 14 limited-disease patients already in complete remission before high-dose therapy the initial result was better, but 11 (79%) have now relapsed following overall median response duration of 10 months. High-dose cyclophosphamide after conventional chemotherapy is feasible and achieves a high response rate, but it does not appear to be associated with significant survival benefit either overall or in patient subgroup. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|